| Particulars (Rupees in Crores.) | Sept-2025 | Mar-2025 | Sept-2024 | Mar-2024 | Sept-2023 |
|---|---|---|---|---|---|
Gross Sales | 1,500.6 | 1,361.4 | 1,329.8 | 1,178.1 | 1,137.1 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,500.6 | 1,361.4 | 1,329.8 | 1,178.1 | 1,137.1 |
Other Operating Income | 10.8 | 13.6 | 4.1 | 7.7 | 4.9 |
Other Income | 4.4 | 4.6 | 14.9 | 7.4 | 6.5 |
Total Income | 1,515.8 | 1,379.6 | 1,348.8 | 1,193.2 | 1,148.5 |
Total Expenditure | 1,367 | 1,170.2 | 1,159 | 1,010.9 | 1,022.9 |
PBIDT | 148.8 | 209.4 | 189.8 | 182.3 | 125.6 |
Interest | 18.2 | 7.5 | 4.5 | 12.4 | 11.6 |
PBDT | 130.6 | 201.9 | 185.3 | 169.9 | 114 |
Depreciation | 35.9 | 18.4 | 10 | 11.8 | 12 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 9.7 | 0.1 | 0.1 | 0.4 | -0.2 |
Deferred Tax | 9.9 | 5.1 | 6.6 | 7.1 | -14.1 |
Reported Profit After Tax | 75.1 | 178.3 | 168.6 | 150.6 | 116.3 |
Minority Interest After NP | 0 | 0 | 0 | 0 | 0 |
Net Profit after Minority Interest | 75.1 | 178.3 | 168.6 | 150.6 | 116.3 |
Extra-ordinary Items | -27.12 | 0 | 5.67 | 0 | -14.2 |
Adjusted Profit After Extra-ordinary item | 102.22 | 178.3 | 162.93 | 150.6 | 130.5 |
EPS (Unit Curr.) | 2.36 | 28.03 | 26.5 | 23.68 | 20.51 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 63.6 | 63.6 | 63.6 | 63.6 | 63.6 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 9.91 | 15.38 | 14.27 | 15.47 | 11.04 |
PBDTM(%) | - | - | - | - | - |
PATM(%) | 5 | 13.09 | 12.67 | 12.78 | 10.22 |
For FY25, it reported an adjusted operating profit of £21 million, with margins of 15.6%, ahead of Zydus Wellness’ own margins of about 14%.
With this, the UK company is now a wholly owned subsidiary of Alidac and becomes a step-down subsidiary of Zydus Wellness.
PAT margin came sharply at 1.4% against 0.1% in the same quarter last year.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
